EAVI2020 EAVI2020 on Twitter EAVI2020 on LinkedIn

Instituto de Salud Carlos III (ISCIII)

The Instituto de Salud Carlos III (ISCIII) is the reference for infectious diseases in Spain. It has responsibilities in basic and clinical research, epidemiological surveillance and control of outbreaks including emergent diseases. More than 300 workers collaborate directly in these tasks at the National Centre of Microbiology (CNM).

In the ISCIII it will be set up the central platform for the screening of neutralizing antibodies obtained by different immunogens in animal models and clinical trials. In addition, researchers of Dr. Alcamí group will contribute in the design of new immunogens based on virus transmitted in the acute infection.


Pepe Alcamí

Dr Alcamí (MD, PhD) is the head of the AIDS Immunopathogenesis Unit and Coordinator of the Spanish AIDS Research Network. His work focus on HIV pathogenesis, in particular the molecular mechanisms of HIV latency and the study of the viral envelope and their interactions with HIV receptors and neutralizing antibodies. Laura Capa has a PhD in Immunology and a broad experience in the management of research projects.


Dr. Laura Capa